| Primary |
| Tuberculosis |
54.8% |
| Pulmonary Tuberculosis |
13.5% |
| Meningitis Tuberculous |
11.5% |
| Tuberculous Pleurisy |
4.8% |
| Whipple's Disease |
4.8% |
| Brucellosis |
2.9% |
| Hiv Infection |
2.9% |
| Bubonic Plague |
1.0% |
| Hyperuricaemia |
1.0% |
| Infection |
1.0% |
| Lung Disorder |
1.0% |
| Rheumatoid Arthritis |
1.0% |
|
| Hypersensitivity |
18.4% |
| Anaphylactic Shock |
7.9% |
| Drug Hypersensitivity |
7.9% |
| Vertigo |
7.9% |
| Deafness |
5.3% |
| Irritability |
5.3% |
| Renal Failure |
5.3% |
| Toxic Skin Eruption |
5.3% |
| Tuberculoma Of Central Nervous System |
5.3% |
| Urticaria |
5.3% |
| Alkalosis Hypokalaemic |
2.6% |
| Convulsion |
2.6% |
| Deafness Bilateral |
2.6% |
| Deafness Unilateral |
2.6% |
| Dizziness |
2.6% |
| Dystonia |
2.6% |
| Hearing Impaired |
2.6% |
| Henoch-schonlein Purpura |
2.6% |
| Immune Reconstitution Syndrome |
2.6% |
| Liver Injury |
2.6% |
|
| Secondary |
| Tuberculosis |
30.9% |
| Pulmonary Tuberculosis |
25.9% |
| Rheumatoid Arthritis |
6.6% |
| Product Used For Unknown Indication |
4.9% |
| Meningitis Tuberculous |
4.1% |
| Whipple's Disease |
4.0% |
| Bovine Tuberculosis |
2.9% |
| Disseminated Tuberculosis |
2.8% |
| Extrapulmonary Tuberculosis |
2.6% |
| Tuberculosis Of Central Nervous System |
2.6% |
| Mycobacterium Avium Complex Infection |
2.3% |
| Encephalitis |
2.0% |
| Pericarditis Tuberculous |
1.5% |
| Tuberculous Pleurisy |
1.4% |
| Brucellosis |
1.3% |
| Tuberculous Meningitis |
1.3% |
| Hiv Infection |
1.0% |
| Peritoneal Tuberculosis |
0.8% |
| Subacute Endocarditis |
0.6% |
| Bone Tuberculosis |
0.5% |
|
| Pyrexia |
10.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.1% |
| Hepatotoxicity |
8.1% |
| Tuberculoma Of Central Nervous System |
8.1% |
| Psychiatric Symptom |
6.8% |
| Rash |
6.8% |
| Vomiting |
6.8% |
| Immune Reconstitution Syndrome |
5.4% |
| Renal Impairment |
5.4% |
| Polyneuropathy |
4.1% |
| Steatorrhoea |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Asthma |
2.7% |
| Blood Parathyroid Hormone Increased |
2.7% |
| Drug Hypersensitivity |
2.7% |
| Drug Ineffective |
2.7% |
| Drug Resistance |
2.7% |
| Lichen Planus |
2.7% |
| Oropharyngeal Candidiasis |
2.7% |
| Thrombocytopenia |
2.7% |
|
| Concomitant |
| Pulmonary Tuberculosis |
17.8% |
| Tuberculosis |
16.9% |
| Hiv Infection |
14.0% |
| Product Used For Unknown Indication |
10.1% |
| Disseminated Tuberculosis |
8.6% |
| Mycobacterial Infection |
5.6% |
| Hypertension |
4.6% |
| Drug Use For Unknown Indication |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Mycobacterium Avium Complex Infection |
2.7% |
| Immunosuppression |
2.1% |
| Tuberculosis Of Central Nervous System |
1.9% |
| Brucellosis |
1.5% |
| Extrapulmonary Tuberculosis |
1.5% |
| Type 2 Diabetes Mellitus |
1.3% |
| Bronchopulmonary Aspergillosis |
1.2% |
| Prophylaxis |
1.0% |
| Antiretroviral Therapy |
0.9% |
| Autoimmune Hepatitis |
0.9% |
| Bovine Tuberculosis |
0.9% |
|
| Hepatitis |
9.4% |
| Pulmonary Tuberculosis |
9.4% |
| Vomiting |
9.4% |
| Renal Failure |
5.9% |
| Respiratory Failure |
5.9% |
| Tuberculosis |
5.9% |
| Death |
4.7% |
| Drug Interaction |
4.7% |
| Hypertensive Encephalopathy |
4.7% |
| Pyrexia |
4.7% |
| Uveitis |
4.7% |
| Weight Decreased |
4.7% |
| Atrial Tachycardia |
3.5% |
| Autoimmune Hepatitis |
3.5% |
| Drug Eruption |
3.5% |
| Hepatic Failure |
3.5% |
| Sepsis |
3.5% |
| Urinary Tract Infection |
3.5% |
| Alanine Aminotransferase Increased |
2.4% |
| Aspergillosis |
2.4% |
|
